• CAFs, Lactylation, and Oxaliplatin Resistance in CRC

  2026-08-17

  A 2025 Cancer Letters study links glycolytic cancer-associated fibroblasts to oxaliplatin resistance in colorectal cancer through a lactate–ANTXR1 lactylation pathway. Its experimental framework suggests that disrupting stromal lactate transfer may reduce cancer stemness and improve chemotherapy response, although clinical validation remains necessary.

• Caspase-3 Colorimetric Assay Kit Workflow

  2026-08-17

  Turn apoptosis biology into a practical, quantitative workflow with rapid DEVD-dependent caspase-3 activity detection. This guide connects the assay to macrophage stress research, disease modeling, experimental controls, and troubleshooting strategies for more reliable caspase activity measurement.

• Acetoacetic acid sodium salt for Metabolic Assays

  2026-08-16

  Acetoacetic acid sodium salt enables controlled ketone-body supplementation, calibration, and stress-testing workflows in energy metabolism research. This guide combines practical formulation advice with analytical controls for diabetes metabolic imbalance and diabetic ketoacidosis study models.

• EZ Cap™ EPO mRNA: From Design to Assay

  2026-08-15

  EZ Cap™ EPO mRNA supports controlled human erythropoietin mRNA expression in mammalian research. This article connects Cap 1 and ψUTP engineering with assay controls, delivery decisions, and lessons from targeted spinal cord injury research.

• 2X HyperFusion High-Fidelity Master Mix for CRISPR PCR

  2026-08-14

  Use 2X HyperFusion High-Fidelity Master Mix to generate accurate, blunt-ended amplicons for cloning, CRISPR genotyping, and sequencing-ready workflows. This practical guide connects the mix’s proofreading performance with assay choices inspired by a bufalin–CRISPR/Cas9 nanomedicine study.

• Wortmannin: Reading PI3K Signals with Control

  2026-08-14

  Wortmannin is a PI3K inhibitor that can reveal whether lipid-kinase activity is functionally upstream of cellular entry, survival, or apoptosis. This guide connects mechanistic pharmacology with assay design, using a reovirus entry study to define controls, limitations, and translational relevance.

• Enhanced ECL for Microglial Mechanisms

  2026-08-13

  How sensitive HRP-based western blot chemiluminescence detection can strengthen mechanistic and translational interpretation of ectomesenchymal stem cell therapy in intracerebral hemorrhage.

• Lactate–H3K18la Axis Drives HCC Immune Resistance

  2026-08-13

  This 2026 hepatocellular carcinoma study identifies a lactate-induced H3K18la–KIF20A–c-Myc–PD-L1 pathway that connects glycolytic metabolism with immune checkpoint resistance. Its clinical, molecular, cellular, and xenograft data suggest that glycolysis inhibition may help restore anti-PD-1 activity, although validation in more representative models remains necessary.

• 2-APB and the ER Calcium Cell-Fate Switch

  2026-08-12

  2-APB provides a practical way to interrogate how ER calcium release, calpain activity, autophagy, and apoptosis intersect under metabolic stress. This thought-leadership guide translates findings from Bombyx mori into a rigorous framework for calcium signaling, SOCE, oxidative injury, and preclinical model development.

• Berbamine hydrochloride: Assay Workflow Guide

  2026-08-12

  Build reproducible cytotoxicity, signaling, and ferroptosis-resistance assays with Berbamine hydrochloride while keeping solvent, timing, and cell-context variables under control. The workflow connects practical NF-κB and STAT3 pathway testing with the METTL16–SENP3–LTF ferroptosis framework in hepatocellular carcinoma research.

• CBD, Orofacial Pain, and Affective Recovery

  2026-08-11

  A 2026 mouse study shows that cannabidiol (CBD) can reduce both inflammatory orofacial pain and pain-associated emotional and cognitive deficits. Its most important contribution is a mechanistic framework connecting peripheral CB2 signaling, central CB1 pathways, endocannabinoid changes, inflammation, oxidative stress, and serotonin dynamics.

• KU-60019: ATM Kinase Inhibitor Workflows

  2026-08-11

  KU-60019 enables selective ATM kinase inhibition for DNA damage response studies, glioma radiosensitization, and migration assays. Its high kinase selectivity also supports exploratory combination studies that connect repair signaling with metabolic vulnerability while keeping model-specific limitations visible.

• Mdivi-1 Workflow for DRP1 and Mitochondrial Fission

  2026-08-10

  Mdivi-1 provides a practical chemical probe for separating mitochondrial fission from downstream apoptosis and stress signaling. This workflow connects ECM remodeling, mitochondrial dynamics, apoptosis assays, and ischemic-retina models while emphasizing controls that improve interpretation and reproducibility.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-08-09

  The reference study identifies CD44 as a metabolic dependency of IDH-mutant leukemia, linking R-2HG-driven CD44 induction to pentose phosphate pathway activation, glycolysis suppression, and sustained NADPH production. Its findings support combination strategies that pair mutant-IDH inhibition with CD44-directed perturbation while highlighting the need to address resistance in acute myeloid leukemia.

• DiD Maps Cell Trajectories in Diabetic Periodontitis

  2026-08-08

  DiD (DiDC 18 (5)) provides long-wavelength red membrane labeling for tracking macrophage behavior and cell interactions in complex diabetic periodontitis models. This article explains how to use the probe as a spatial assay layer alongside the ROS–mitochondria–inflammation framework, while avoiding overinterpretation of membrane fluorescence.

8065 records 4/538 page Previous Next 12345 下5页 Last page